Retinol Binding Protein 4 in children with Inflammatory Bowel Disease: a negative correlation with the disease

E Roma1, M Krini, E Hantzi

  • 1First Department of Pediatrics, Athens University Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece.

Hippokratia
|August 13, 2013
PubMed

Insights

Serum Retinol Binding Protein-4 (RBP-4) levels in children with inflammatory bowel disease (IBD) did not differ from controls. However, RBP-4 showed a protective anti-inflammatory role, negatively correlating with disease activity.

Area of Science:

  • Pediatric Gastroenterology
  • Immunology
  • Endocrinology

Background:

  • Retinol Binding Protein-4 (RBP-4) is a key adipocytokine involved in inflammation, beyond its role in vitamin A transport.
  • Understanding RBP-4's role in pediatric inflammatory bowel disease (IBD) is crucial for managing inflammation.

Purpose of the Study:

  • To evaluate serum RBP-4 levels in children diagnosed with IBD.
  • To correlate RBP-4 levels with transthyretin (TTR), inflammation markers (SAA, CRP, ESR), disease activity, and BMI in pediatric IBD patients.

Main Methods:

  • Prospective analysis of serum RBP-4, TTR, SAA, CRP, ESR, disease activity, and BMI in 41 children with IBD (Crohn's disease and Ulcerative Colitis).
  • Comparison with 42 age- and sex-matched healthy controls.
  • Correlation analysis to determine relationships between variables.

Main Results:

  • No significant differences in serum RBP-4 or TTR levels were observed between pediatric IBD patients and controls, or between active and remission disease states.
  • Serum RBP-4 negatively correlated with disease activity, serum amyloid A (SAA), and erythrocyte sedimentation rate (ESR).
  • Inflammation markers (SAA, ESR, CRP) were elevated in IBD patients and positively correlated with disease activity.

Conclusions:

  • Serum RBP-4 levels do not differ in children with IBD compared to controls.
  • RBP-4 appears to possess a protective anti-inflammatory role in pediatric IBD, indicated by its negative correlation with disease activity and inflammation markers.
Abstract

Related Concept Videos

Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...